DZ3050A1 - Formes polymorphes d'un citrate d'azobicydoÄ2,2,2Ü-octane-3-amine cristallin et leurs compositions pharmaceutiques. - Google Patents

Formes polymorphes d'un citrate d'azobicydoÄ2,2,2Ü-octane-3-amine cristallin et leurs compositions pharmaceutiques.

Info

Publication number
DZ3050A1
DZ3050A1 DZ000101A DZ000101A DZ3050A1 DZ 3050 A1 DZ3050 A1 DZ 3050A1 DZ 000101 A DZ000101 A DZ 000101A DZ 000101 A DZ000101 A DZ 000101A DZ 3050 A1 DZ3050 A1 DZ 3050A1
Authority
DZ
Algeria
Prior art keywords
octane
crystalline
pharmaceutical compositions
polymorphic forms
amine citrate
Prior art date
Application number
DZ000101A
Other languages
English (en)
Inventor
Michael James Castaldi
George Joseph Quallich
Lewin Theophilus Wint
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DZ3050A1 publication Critical patent/DZ3050A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DZ000101A 1999-06-01 2000-05-31 Formes polymorphes d'un citrate d'azobicydoÄ2,2,2Ü-octane-3-amine cristallin et leurs compositions pharmaceutiques. DZ3050A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13699299P 1999-06-01 1999-06-01

Publications (1)

Publication Number Publication Date
DZ3050A1 true DZ3050A1 (fr) 2004-03-27

Family

ID=22475338

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ000101A DZ3050A1 (fr) 1999-06-01 2000-05-31 Formes polymorphes d'un citrate d'azobicydoÄ2,2,2Ü-octane-3-amine cristallin et leurs compositions pharmaceutiques.

Country Status (48)

Country Link
US (1) US6255320B1 (fr)
EP (1) EP1181290B1 (fr)
JP (1) JP3830816B2 (fr)
KR (1) KR100476606B1 (fr)
CN (1) CN1146565C (fr)
AP (1) AP2001002349A0 (fr)
AR (1) AR033331A1 (fr)
AT (1) ATE244239T1 (fr)
AU (1) AU767334B2 (fr)
BG (1) BG65240B1 (fr)
BR (1) BR0011094A (fr)
CA (1) CA2372238C (fr)
CO (1) CO5170463A1 (fr)
CY (1) CY2007011I2 (fr)
CZ (1) CZ295819B6 (fr)
DE (1) DE60003679T2 (fr)
DK (1) DK1181290T3 (fr)
DZ (1) DZ3050A1 (fr)
EA (1) EA003731B1 (fr)
EC (1) ECSP003508A (fr)
EE (1) EE200100656A (fr)
ES (1) ES2199825T3 (fr)
GT (1) GT200000087A (fr)
HN (1) HN2000000077A (fr)
HR (1) HRP20010904A2 (fr)
HU (1) HUP0201301A3 (fr)
IL (1) IL146406A0 (fr)
MA (1) MA26742A1 (fr)
MX (1) MXPA01012325A (fr)
MY (1) MY133508A (fr)
NO (1) NO20015848L (fr)
NZ (1) NZ515349A (fr)
OA (1) OA11956A (fr)
PA (1) PA8496101A1 (fr)
PE (1) PE20010209A1 (fr)
PL (1) PL196046B1 (fr)
PT (1) PT1181290E (fr)
SI (1) SI1181290T1 (fr)
SK (1) SK285820B6 (fr)
SV (1) SV2001000093A (fr)
TN (1) TNSN00120A1 (fr)
TR (1) TR200103473T2 (fr)
TW (1) TWI285204B (fr)
UA (1) UA66925C2 (fr)
UY (1) UY26176A1 (fr)
WO (1) WO2000073304A1 (fr)
YU (1) YU81101A (fr)
ZA (1) ZA200109775B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2638113T3 (es) * 2004-01-30 2017-10-18 Zoetis Services Llc Conservantes antimicrobianos para lograr una formulación de dosis múltiples usando ciclodextrinas beta para formas de dosificación líquidas
KR100880391B1 (ko) * 2004-01-30 2009-01-30 화이자 프로덕츠 인크. 마취 회복 개선용 ｎｋ-1 수용체 길항제
MXPA06008648A (es) * 2004-01-30 2006-09-04 Pfizer Prod Inc Composiciones farmaceuticas de antagonistas del receptor de neuroquinina y ciclodextrina y metodos para una tolerancia mejorada en el sitio de inyeccion.
ES2296131T3 (es) * 2004-02-02 2008-04-16 Pfizer Products Incorporated Procedimiento para la preparacion de 1-(2s,3s)-2-bencidril-n-(5-terc-butil-2-metoxibencil)quinuclidin-3-amina.
US20140275517A1 (en) * 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
CN110577522B (zh) * 2018-06-07 2022-12-27 东莞市东阳光动物保健药品有限公司 马罗匹坦柠檬酸盐新晶型及其制备方法
CN112979639B (zh) * 2019-12-16 2025-08-08 凯默斯医药科技(上海)有限公司 一种马罗皮坦新晶型及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2102179C (fr) * 1991-05-31 1998-10-27 Fumitaka Ito Derives quinuclidine
US5393762A (en) * 1993-06-04 1995-02-28 Pfizer Inc. Pharmaceutical agents for treatment of emesis
US5576317A (en) * 1994-12-09 1996-11-19 Pfizer Inc. NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis

Also Published As

Publication number Publication date
DK1181290T3 (da) 2003-09-29
OA11956A (en) 2006-04-13
WO2000073304A1 (fr) 2000-12-07
UA66925C2 (uk) 2004-06-15
EE200100656A (et) 2003-02-17
YU81101A (sh) 2004-07-15
JP2003501354A (ja) 2003-01-14
HRP20010904A2 (en) 2003-02-28
HUP0201301A2 (en) 2002-08-28
PL196046B1 (pl) 2007-11-30
DE60003679D1 (de) 2003-08-07
HUP0201301A3 (en) 2002-10-28
KR20020010688A (ko) 2002-02-04
JP3830816B2 (ja) 2006-10-11
CZ295819B6 (cs) 2005-11-16
ES2199825T3 (es) 2004-03-01
CN1146565C (zh) 2004-04-21
NZ515349A (en) 2004-03-26
NO20015848D0 (no) 2001-11-30
CA2372238C (fr) 2006-12-19
AU767334B2 (en) 2003-11-06
SI1181290T1 (en) 2003-12-31
CZ20014269A3 (cs) 2002-04-17
CN1353711A (zh) 2002-06-12
EP1181290B1 (fr) 2003-07-02
SV2001000093A (es) 2001-11-08
ECSP003508A (es) 2002-02-25
HN2000000077A (es) 2001-02-02
KR100476606B1 (ko) 2005-03-18
TWI285204B (en) 2007-08-11
TR200103473T2 (tr) 2002-04-22
ZA200109775B (en) 2002-11-28
CO5170463A1 (es) 2002-06-27
NO20015848L (no) 2001-12-18
US6255320B1 (en) 2001-07-03
MY133508A (en) 2007-11-30
BG106204A (en) 2002-07-31
PE20010209A1 (es) 2001-03-01
MXPA01012325A (es) 2002-07-22
AU4424800A (en) 2000-12-18
ATE244239T1 (de) 2003-07-15
SK17332001A3 (sk) 2002-07-02
AR033331A1 (es) 2003-12-17
EA003731B1 (ru) 2003-08-28
DE60003679T2 (de) 2004-05-27
UY26176A1 (es) 2000-12-29
BR0011094A (pt) 2002-03-19
CY2007011I1 (el) 2010-07-28
HK1046284A1 (en) 2003-01-03
PT1181290E (pt) 2003-09-30
CA2372238A1 (fr) 2000-12-07
EA200101108A1 (ru) 2002-04-25
CY2007011I2 (el) 2010-07-28
AP2001002349A0 (en) 2001-12-31
GT200000087A (es) 2001-11-22
MA26742A1 (fr) 2004-12-20
SK285820B6 (sk) 2007-09-06
EP1181290A1 (fr) 2002-02-27
IL146406A0 (en) 2002-07-25
PA8496101A1 (es) 2002-07-30
PL352716A1 (en) 2003-09-08
TNSN00120A1 (fr) 2005-11-10
BG65240B1 (bg) 2007-09-28

Similar Documents

Publication Publication Date Title
FR2775596B1 (fr) Nouvelles compositions pharmaceutiques
MA26673A1 (fr) Composes pharmaceutiques
TR200003788A3 (tr) Yavas salimli oral dozaj bilesim.
FR2789079B3 (fr) Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
MA26816A1 (fr) Derives d'amino-triazolopyridine
NO20015175L (no) Farmasöytisk sammensetning
ID26743A (id) Turunan 1,2,4,5-tetrahidro-benzo [d] azepin
FR2761265B1 (fr) Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino-3-pyrazolecarboxamide, de ses sels et de leurs solvates
FI991485L (fi) Uusi farmaseuttinen koostumus
PT1242087E (pt) Composicoes farmaceuticas
DK1095932T3 (da) Phenoxyeddikesyrederivat og pharmaceutiske sammensætninger omfattende den samme
MA26968A1 (fr) Compositions pharmaceutiques contenant du maleate d'amlodipine.
NO20014738D0 (no) Tolperisonholdig farmasöytisk preparat for oral administrering
NO20015670L (no) Forbedrede farmasöytiske formuleringer
NO20002686L (no) Forbedring av Peyronies sykdom
EE200200281A (et) Pikornaviirusevastased ühendid ja kompositsioonid, nende farmatseutilised kasutusalad ning ained nende sünteesiks
DK1200118T3 (da) En farmaceutisk sammensætning omfattende megalatran og dens prodrug
CY2007011I1 (el) Πολυμορφες ενος κρυσταλλικου κιτρικου αλατος αζαδικυκλο (2,2,2) οκταν -3- αμινης και φαρμακευτικες συνθεσεις τους
FR2792529B1 (fr) Nouvelles compositions pharmaceutiques comprenant des derives de 2-isoxazole-8-aminotetralines
FR2833842B1 (fr) Compositions pharmaceutiques a base de derives d'azetidine
PT1239832E (pt) Composicoes farmaceuticas
DZ3055A1 (fr) Polymorphes d'un chlorhydrate d'azo-bicyclo-2,2,2-oct-3-ylamine cristallins et compositions pharmaceutiques les contenant.
FR2779145B1 (fr) Nouvelles compositions pharmaceutiques
FI4488U1 (fi) Farmaseuttinen koostumus
FR2797444B1 (fr) Compositions pharmaceutiques comprenant des 4-quinolones